Introduction
Some of the smallest self-replicating bacteria, the wall-less mycoplasmas belonging to Class Mollicutes, are pathogenic for mammals and humans, showing tissue and host-specificity. In humans, the pathogenic species of the Mycoplasma or Ureaplasma genus cause covert infections that tend to chronic diseases. At present, 7 species of Mycoplasma, 2 species of Ureaplasma and 1 of Acholeplasma have been consistently isolated/detected from several specimens from diseased subjects, specially through the use of molecular detection techniques [Mendoza et al., 2011; Waites & Talkington, 2005; Waites, 2006] . Current laboratory diagnosis of these infections relies on cultural methods, however this is complicated and emission of results may delay up to 5 weeks. Thus development and application of molecular methods, such as polymerase chain reaction (PCR), have allowed direct detection in clinical specimens and shortened the time to get the final results. Nevertheless some pitfalls still hampers the widespread use of these technologies, mainly due to technical difficulties in collecting representative specimens and optimizing sample preparation. There are countless reports on new nucleic acid-based tests (NATs) for mycoplasma detection, however there is a great variation between methods from study to study, including variability of target gene sequences, assay format and technologic platform [Waites et al., 2000; Waites , 2006; ] .
The processing of the clinical samples is crucial for the improvement of PCR assays as part of routine diagnostic approaches. In general, for the strength of performance of any diagnostic PCR, the overall setting-up of the assay should consider the following four basic steps: 1) sampling, 2) sample preparation, 3) nucleic acid amplification, and 4) detection of PCR products [Rådström et al., 2004] .
As occurred with much of the emerging or reemerging pathogens, the molecular detection plays a key role in the discovery, identification and association or such pathogens with human disease [Relman & Persing, 1996] . Nevertheless, routine clinical microbiology +  +  +  +  +  +  +  +  +  --¿?  -+  +  +  ¿?   ------+  +  +  +  +  ¿?  +  +  +  -------+  -+  +  --+  +  --+  +   +  +  +  +  +  -+  -+  +  +  +  +  -----------------+  +  -------+  +  +  + a  ---+ b,c  +  +  -- a Lo et al,1993; Lo et al, 1992; Yáñez et al., 1999. and M. penetrans are primarily urogenital residents, but exceptionally they can be isolated from other unusual tissues and organs, especially in immunocompromised patients or in patients undergoing solid organ transplantation [Cassel et al., 1993; Waites & Talkington, 2004; Waites et al., 2008] .
Most of mycoplasmal diseases are underdiagnosed because the specific laboratory diagnostic strategies are quite different than those for fast-growing bacteria. It is noteworthy that mycoplasmal etiology of diseases in humans is considered only after failure of diagnosis of other common bacterial etiologies. In addition, outside their hosts, the mycoplasmas are highly labile to environmental factors, such as changing osmotic pressure and temperature, desiccation and/or alkaline or acidic conditions [Cassell et al., 1994a; Waites et al., 2000] . Noteworthy, there are few specialized or reference laboratories for diagnosis of mycoplasmal diseases and therefore, limited skilled laboratory personnel [Cassell et al., 1994a] .
Routine laboratory diagnostic approaches
Several different detection techniques of mycoplasmal infections have been developed, each one of which has its advantages and limitations with respect to cost, time, reliability, specificity, and sensitivity. According to the laboratory's infrastructure, the most common methods include: a) culture-based isolation/detection/identification/antimicrobial susceptibility profile; b) antigen detection, c) mycoplasmal-specific serologic responses; and, d) PCR and other NATs. [Razin et al., 1998; Talkington & Waites, 2009; Waites et al., 2000; Yoshida et al., 2002] .
Culture
Relationship between mycoplasmas as etiologic agents and diseases in humans remains doubtful due to unsuccessful isolation/detection of these microorganisms in specimens from affected persons, as compared with healthy carriers [Taylor-Robinson, 1996] . Demonstration of growth of mycoplasma, by means of in vitro culture from clinical specimens, is still required to link the pathogen with the disease; thus culture is considered as the Gold Standard. However, current culture methods for detection of mycoplasmas in clinical specimens are arduous and emission of results may delay up to 5 weeks, which even then may be inconclusive or inaccurate [Cassell et al., 1994a; Waites et al., 2000] .
In this context, detection or isolation of mycoplasmas from clinical specimens requires careful consideration of the type of specimen available and the organism (species) sought [Cassell et al., 1994a] . The adequate specimens for culture include: a) normally sterile body fluids (sinovial, amniotic, cerebrospinal, urine, peritoneal, pleural, etc., b) secretions exudates or swabs from sites with associated flora (from nasopharinx, pharinx, cervix, vagina, urethra, surgical wounds, prostate, sputum, etc.) , and c) cell-rich fluids (including blood and semen) or tissue biopsies. Overall, specimen collection should reflect the site of infection and/or the disease process. Waites & Talkington, 2004] .
Liquid specimens or tissues do not require special transport media if culture can be performed within 1 hour, otherwise specimens should be placed in transport media, such as SP-4, 10B or 2SP broths. When swabbing is required, aluminum-or plastic-shafted calcium alginate or dacron swabs should be used, taking care to obtain as many cells as possible Cassell et al., 1994a; Waites, 2006] .
There is no ideal formulation of culture media for all pathogenic species, mainly due to their different substrate and pH requirements [Waites et al., 2000] . Modified SP-4 media (broth and agar) [Lo et al., 1993a] , containing both glucose and arginine, can support the growth of all human pathogenic Mycoplasma species, including the fastidious M. pneumoniae and M. genitalium. A set of Shepard´s 10B broth and A8 agar can be used for cultivation of Ureaplasma species and M. hominis. For cultivation, specimens in transport media should be thoroughly mixed, and then should be 10-fold serially diluted in broth (usually up to 10 -6 ) in order to allow semiquantitative estimation of mycoplasmal load, but subcultures in agar media should also be performed [Cassel et al., 1994a] . Inoculated media should be incubated under microaerophilic atmosphere at 37 °C.
Detection of M. pneumoniae in broth culture is based on its ability to ferment glucose, causing an acidic shift after 4 or more weeks, readily visualized by the presence of the phenol red pH indicator. Broths with any color change, and subsequent blind broth passages, should be subcultured to SP4 agar, incubated, and examined under the low-power objective of the light microscope in order to look for development of typical "fried egg"-like colonies of up to 100 μm in diameter. Examination of agar plates must be done on a daily basis during the first week, and thereafter every 3 to 4 days until completing 5 weeks or until growth is observed [Waites et al., 2000; Waites & Talkington, 2004] . M. genitalium, M. fermentans and M. penetrans are also glucose-fermenting and form colonies morphologically indistinguishable from those of M. pneumoniae, thus serologic-based definitive identification can be done by growth inhibition, metabolic inhibition, and mycoplamacidal tests .
Hidrolysis of urea by Ureaplasma and hidrolysis of arginine by M. hominis cause an alkaline shift, turning the colour of 10B broth from yellow to pink. Tiny brown or black irregular colonies of Ureaplasma species develop between 1-5 days on A8 agar plates, due to urease activity in the presence of manganese sulfate. Typical fried egg colonies are produced by M. hominis in this medium [Cassell et al, 1994a; Waites et al., 2000] .
Molecular assays
The nucleic acid-based techniques have several advantages over culture-based methods, including rapid results, low detection limits (theoretically a single copy of target sequence), and specific organism detection. This is critical in a hospital setting, since rapid pathogen detection is important for faster and improved patient treatment and consequently for shortening hospitalization time [Mothershed & Whitney, 2006] .
In particular, for PCR-based detection tests, selection of the appropriate target sequences for amplification appears to be of major concern. Mycoplasmal sequences to be amplified can be chosen from published gene sequences or from a mycoplasma-specific cloned DNA fragments [Kovacic et al., 1996; Razin, 2002] . The accelerated rate of genomic sequencing has led to an abundance of completely sequenced genomes. Annotation of the open reading frames (ORFs) (i.e., gene prediction) in these genomes is an important task and is most often performed computationally based on features in the nucleic acid sequence [Jaffe et al., 2004; Razin 2002] . Besides complete or almost complete sequences of the 16S rRNA genes for almost all the established mycoplasma species, the published full genome sequences of the human pathogenic mycoplasma species [Fraser et al., 1995; Glass et al., 2000; Himmelreich et al., 1996] will accelerate the process of identification of novel target sequences for PCR diagnostics. Selection of a variety of target sequences, starting with highly conserved regions of the genes, allowed design of primers of wide specificity ("universal primers") ( Table 2) for detection of mycoplasmal infections in anatomic sites where at least 2 or 3 species are frequently found. The use of a single Mollicutes universal primer set in cases of life-threatening infections has the advantage of allowing a rapid positive or negative report to clinicians, and in turn to establish as soon as possible the appropriate treatment [Razin, 1994] . The approach of using Mollicutes-specific and Ureaplasma spp-specific universal primers allowed better discrimination between organisms of the Mycoplasma and Ureaplasma genus, and subsequent identification by species-specific primers in urine specimens from HIV-infected patients [Díaz-García et al., 2004] .
Targets
Applications References
16S rRNA gene sequence
Conserved regions of mycoplasmal 16S rRNA genes.
Screening for any mycoplasma species in clinical specimens and cell cultures.
van Kuppeveld et al., 1992; van Kuppeveld et al., 1994; Yoshida et al., 2001 .
Variable regions of mycoplasmal 16S rRNA genes:
Species-specific detection. Blanchard et al., 1993a; Grau et al., 1994; 1992.
The 16S-23S intergenic regions Detection of cell culture contamination. Harasawa et al., 1993 .
Mycoplasmal protein genes
P1 adhesin gene: M. pneumoniae Selective detection and typing Bernet et al., 1989 MgPa adhesin gene: M. genitalium Selective detection Palmer et al., 1991; Jensen et al., 1991. Elongation factor tuf gene of M. pneumoniae Selective detection Lüneberg et al., 1993 Ureasa genes: Ureaplasma spp. Genus-specific detection Blanchard et al., 1993b tet M gene (tetracycline-resistance determinant)
Identification of tetracycline-resistant strains Blanchard et al., 1992 Mba gene Species-specific detection and typing. Kong et al., 1996 Repetitive genomic sequences Is-like elements: M. fermentans Selective detection Rep elements of P1: M. pneumoniae Selective detection Ursi et al., 1992 When differentiation of the mycoplasmas is required, a multiplex PCR system consisting of a universal set of primers along with primer sets specific for the mycoplasma species commonly involved in a given disease process can be successfully applied [Razin, 2002 , Choppa et al., 1998 ]. Moreover, both conserved and variable regions within the mycoplasmal 16S rRNA genes can also be selected for detection at cluster-, genus-species-, subspecies-, biovar-or serovar-specific levels [Kong et al., 2000; Razin, 2002] .
For diagnostic purposes in mycoplasmology, the nucleic acid tests are more sensitive than culture, and showing a fair to good correlation with serology. PCR testing for speciesspecific mycoplasmal infection are suitable for both urogenital and respiratory samples [Povlsen et al., 2001 [Povlsen et al., , 2002 . Interestingly, sample processing prior amplification must be optimized depending of the type of specimen to overcome the presence of undefined inhibitory substances for DNA polymerases, avoiding false negative results. For example, nasopharyngeal samples have a higher rate of PCR inhibition than throat swabs. In general, results obtained by means of NATs will be as good as the quality of the nucleic acid used for the test [Mothersehed & Whitney, 2006; Maeda et al., 2004] .
Early in the past decade, Loens et al., 2003b , stated that the development and application of new nucleic acid tests (NATs) in diagnostic mycoplasmology required proper validation and standardization, and performance of different NATs must be compared with each other in order to define the most sensitive and specific tests. The NATs have demonstrated their potential to produce rapid, sensitive and specific results, and are now considered the methods of choice for direct detection of M. pneumoniae, M. genitalium, and M. fermentans [Cassell et al., 1994a; Loens et al., 2003b] . There is a great variation in methods used from study to study, including variability of target gene sequences (P1, 16S RNA, ATPase, tuf), assay format (single, multiplex) or technologies (end-point PCR, Realtime PCR, NASBA) [Loens et al., 2003a [Loens et al., , 2003b . Also, target DNA has been obtained from different specimens, such as sputum, nasopharyngeal or pharyngeal swabs, brochoalveolar lavages or pleural fluid, and then comparisons of performance between these assays are difficult. For comprehensive understanding of the use of NATs for the detection of M. pneumoniae, genital mycoplasmas and other respiratory pathogens in clinical specimens, see the reviews done by Ieven, 2007; ; Lo & Kam, 2006; Loens et al., 2003b Loens et al., , 2010 As with any other diagnostic test, PCR assays designed for mycoplasma detection in the clinical setting offer several advantages over other non-molecular tests, but still have several drawbacks to take into account (Table 3) . Notwithstanding, there are several primer sets that have been successfully applied for diagnosis of mycoplasmal diseases in humans (Table 4) .
Importance of the specimen collection and processing
Clinical specimens must be collected with use of strict aseptic techniques from anatomic sites likely to yield pathogenic microorganisms [Taylor, 1998; Wilson, 1996] . In the case of mycoplasmal infections, these are clinically silent or covert, thus it is important to differentiate between asymptomatic carriage and disease. In this context, sampling of representative diseased body sites is critical for successful diagnosis.
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The usefulness of a PCR assay for diagnostic purposes is rather limited; this is partially explained by the presence of inhibitory substances in complex biological samples, which then provoke a significant reduction or even blockage of the amplification activity of DNA polymerases in comparison with that obtained with the use of pure solutions of nucleic acids. This in consequence affects the performance and the analytical sensitivity of the PCR assays [Lo & Kam, 2006; Vaneechoute & Van Eldere, 1997] .
Advantages Disadvantages
• Overcomes the need for mycoplasma cultivation
• Presence of undefined inhibitors of DNA polymerases may yield falsenegative results.
• Emission of results is faster than culture (less than 24 h vs. up to 5 weeks)
• Upon detection, PCR poorly discriminates between disease or carriage
• Allows detection of antibioticinhibited or uncultivable species in clinical specimens
• Risk of false-positive results due to carryover contamination with amplicons from previous reactions.
• Selective detection. Presence of nucleic acids from the host or from other microorganisms usually do not affect PCR results
• Setting-up quantitative determination of bacteria in clinical specimens may be a very complicated task.
• Higher sensitivity than other nonmolecular diagnostic assays (culture, serology).
• Performance of PCR assays for routine diagnostic purposes in microbiology laboratories is still complex and expensive.
• Use as an epidemiological tool since it allows detection of asymptomatic carriers.
• Skilled personnel are required to carry out tests and analysis of results.
• Allows detection of mycoplasmas at the level of Family, Genus, Species, Subspecies and/or Type.
• Depending on the target sequences used, cross reactivity with closely related bacteria may occur. Table 3 . Considerations for using PCR assays in diagnosis of mycoplasma infections. Adapted from: Razin 1994.
Due to the above mentioned, improvement of PCR assays for routine diagnostic purposes clearly should begin with optimal processing of clinical specimens prior to amplification reaction, thus successful amplification of the target DNA sequence can be obtained in the context of trace amounts of sample-associated inhibitory substances [Horz et al, 2010; Lo & Kam, 2006; Rådström et al., 2004; Vaneechoute & Van Eldere, 1997] . 
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Under certain conditions PCR detection/identification/confirmation of mycoplasmas could be attempted from culture broths used for primary isolation, whether or not it have bacterial growth. According to broth turbidity boiling of small aliquots can be sufficient to release the DNA, but presence of precipitated material may inhibit the amplification assay.
In our experience, an alkaline shift around pH 8 frequently results in bacterial lysis, mainly of ureaplasmas, therefore concentration of insoluble material by ultracentifugation prior to DNA extraction is unproductive. This is due to spontaneous release of mycoplasmal DNA that easily dissolves in the aqueous phase and cannot be sedimentated by centrifugation. In such cases, one can take advantage of the alkaline condition to precipitate the dissolved DNA by adding one tenth of 1M NaCl and twice the volume of cold 100% ethanol, and proceed with conventional DNA extraction protocols (unpublished data).
Exudates and secretions
These types of specimens are fluids closely associated with mucosal surfaces, in low quantities, so collection should be done with the aid of swabs, cytological brush or small syringes. Secretions and exudates can be taken from upper respiratory airways and from lower genital tract, and exceptionally from surgical wounds [Waites, 2006] .
Respiratory tract
Respiratory M. pneumoniae infection can be assessed by culture and PCR in nasopharyngeal and oropharyngeal secretions, sputa, bronchoalveolar lavage and lung tissue obtained by biopsy. There are reports that nasopharyngeal and oropharyngeal specimens are equally effective for detection of M. pneumoniae by PCR, although it is desirable that both sites are screened in parallel for better diagnostic yield .
When neonatal mycoplasmal infections are suspected, endotracheal, nasopharyngeal and throat secretions are appropriate to evaluate respiratory infection., though specimens for culture should be transported quickly to laboratory since they are likely to contain at least a few contaminating microorganisms .
Presence of mucous material in this kind of specimens frequently hampers appropriate processing for culture or PCR. Use of aggressive mucolytic agents (NaOH, n-acetyl-cisteine) can damage as well the mycoplasma cells, thus thorough homogenization by wide-bore pippeting is required prior to culture attempt. For nucleic acid extraction, addition of starch has been of help to enhance recovery of total genomic DNA from sputum samples . In other study, dithiotreitol was used as the mucolytic agent without any apparent detrimental effect on mycoplasmal DNA integrity [Raty et al., 2005] .
It this worthy to note that differential sample preparation from the same specimen may be necessary when testing separate single-species PCRs on BAL, as described by [de Barbeyrac et al., 1993] . In that report, freeze-thawing cycles were applied for sample preparation for M. genitalium detection, while standard DNA extraction was needed for M. pneumoniae detection. During a study of Finnish patients with radiologically confirmed pneumonia, [Raty et al., 2005] , evidence further supported the notion that selection of the appropriate specimen is crucial for diagnosis of M. pneumoniae infection. By means of a M. pneumoniae-specific 16S rDNA PCR, they obtained positive amplification frequencies of 69%, 50% and 37.5% for sputum, nasopharyngeal aspirate and throat swab specimens, respectively.
Urogenital tract
Since genital tract mycoplasmas are closely associated to live epithelial cells, collection of exudates must be avoided and vigorous scraping of epithelia must be done to obtain as many cells as possible. In this case, a higher associated flora is frequently present in the samples; therefore use of transport liquid media (for culture) of buffered solutions (for DNA extraction) is required immediately after sampling.
Sterile body fluids
Collection of normally sterile body fluids is made through invasive procedures, usually performed by physicians under aseptic conditions [Wilson, 1996] . When specimens are going to be collected through puncture, careful disinfection of the skin spot must be done, this is crucial to both avoid contamination of the specimen with the skin's associated flora and to minimize the risk of introduction of bacteria into patient's body. Clinically, access of mycoplasmas to sterile body sites may be associated with an underlying immune compromise, and probably the bacteria spread from pulmonary or genital infectious foci [Cassell et al., 1994b; Waites & Talkington, 2004] . Ureaplasmas and mycoplasmas should always be sought from synovial fluid when hypogammaglobulinemic patients develop acute arthritis [Waites et al., 2000] .
Since mycoplasma-containing body fluids rarely became turbid; these specimens should be concentrated 10-fold by high-speed centrifugation (aprox. 12,000 x g) and immediately resuspended in one tenth of the original supernatant if culture will be performed. Prior to DNA extraction, the resulting pellet can be washed 1-2 times with Hank's balanced salt solution or PBS, pH 7.4.
Cell-rich fluids and tissues
Unlike normally sterile body fluids, blood and semen are cell-rich fluid specimens, thus processing for culture or PCR is quite different. It is important to note that mycoplasmas have the ability to invade several cell types, including leukocytes and spermatozoa [Andreev et al., 1995; Baseman et al., 1995; Díaz-García et al., 2006; Girón et al., 1996; Jensen et al., 1994; Lo et al., 1993b , Rottem, 2003 Yavlovich et al., 2004] , consequently a high input of cells into culture media may result in a higher probability of detection.
In contrast, when DNA extraction must be performed for PCR assays, depuration of the sample must be done, (i.e. erythrocyte lysis and selective enrichment for leukocytes in blood; density gradient-based purification of spermatozoa). Noteworthy, the average content of leukocyte DNA per milliliter of blood ranges from 32 to 76 µg, therefore surpasses considerably the amount of bacterial DNA in a specimen from an infected subject. [Greenfield & White, 1993] , so a high amount of sample DNA should be added to the PCR reaction mixture to raise the chances to detect bacterial target sequences.
In the case of solid tissues, mechanical homogenization is required to release single cells, either for culture or DNA extraction. A challenge for DNA extraction is when tissues have been formalin-fixed and/or paraffin-embedded since there is high risk of DNA damage [Shi et al., 2004] .
A summary of the processing of different specimen types for intended mycoplasma detection is depicted in Figure 1 . Fig. 1 . Differential specimen processing for mycoplasma detection.
Culture vs. nucleic acid amplification methods

The gold standard for mycoplasmal infections
Some genital mycoplasmas, Ureaplasma spp. and M. hominis, are the fastest growing species among the Mollicutes, and due to this, culture-based detection is still the first-line diagnostic approach. However, extrapolating this particular feature to all pathogenic human mycoplasmas is inaccurate. PCR amplification has become essential if fastidious, slow-growing, mycoplasma species are sought in certain clinical conditions, especially in patients with high risk of invasive infections (neonates) or when invasive methods of sampling are required . It is well recognized that culture techniques are of poor or null value for detection of some mycoplasma species (i.e. M. genitalium) [Razin et al., 1998 ]. Since culture rely on viability of mycoplasmas to give a positive result, analytical comparisons between culture and PCR invariably will regard the second as less sensitive and less specific, which by any means is wrong. The PCR assay ideally detect target DNA sequences present in the sample, whether it comes from live, dead or uncultivable bacteria [Persing, 1993] .
Performance of non culture-based detection tests is frequently evaluated against culture, as the gold standard. Indirect assays measuring serologic responses as correlates of mycoplasma infections, have shown poor sensitivity and required at least 2 serum samples taken several days apart, to be informative [Waites, 2000] .
Culture-enhanced PCR approach
When very few mycoplasma cells are present in a given specimen there is a high probability of obtaining false-negative results, even when the sensitivity of the specific PCR assay is high. To overcome this, several authors have developed culture-based pre-enrichment protocols for mycoplasmas, mycobacteria and Actinobacillus [Abele-Horn et al., 1998; Díaz-García et al., 2004; Flemmig et al., 1995; Noussair et al., 2009] . The effects of this procedure are, on one hand the dilution of potential undefined inhibitors, and on the other hand the promotion of short-term bacterial multiplication. This experimental approach has been termed as Culture-enhanced PCR (CE-PCR) [Abele-Horn et al., 1998 ]. The genomic DNA content in overnight enriched mycoplasma cultures are extracted by standard or commercial techniques, and then subjected to broad-range or species-specific PCR assays. Under this approach, improved detection of M. pneumoniae has been achieved in respiratory specimens [Abele-Horn et al., 1998 ], and of genital mycoplasmas in urine specimens [Díaz-García et al., 2004] .
Another culture-based enrichment approach for improvement of PCR detection of mycoplasmas is the cocultivation of these bacteria with permissive immortalized mammalian and/or insect cell lines [Kong et al., 2007; Volokhov et al., 2008] . Although this approach has been design for intentional screening of cell-derived biological and pharmaceutical products, including vaccines and cell culture substrates, it is a potential tool for biological enrichment of normally-sterile clinical specimens such as CFS, sera, synovial fluid, etc.
Interestingly, strains of mycoplasma-free Trichomonas vaginalis are readily infected in vitro by M. hominis isolates, but not by other urogenital mycoplasmas. The infection can be detected by a M. hominis-specific PCR assay after long-term incubation, since the mycoplasma can be transmitted between the protozoan cells [Dessi et al., 2006; Rapelli et al., 2001] . The symbiotic interplay between M. hominis and T. vaginalis has been well established, as well a significant correlation between detection of both microorganisms in vaginal specimens from infected women [Dessi et al., 2006] . Thus it is likely to take advantage of such symbiosis and employ mycoplasma-free T. vaginalis cultures for specific enrichment of M. hominis-containing clinical specimens prior to PCR detection tests.
Commercial molecular diagnostic kits
Unlike the in-house PCR assays for diagnostic purposes, developed by several researchers, the commercial PCR kits are well standardized in terms of sensitivity and specificity, (Minerva Biolabs GmbH) . It has been shown that these commercial kits had acceptable analytical sensitivity and performance with clinical specimens [Touati et al., 2009] .
Interestingly, many commercially available extraction kits incorporate a buffer to lyses the bacteria and a silica matrix membrane (typically in column format) to trap the DNA or RNA. Several wash steps are required to remove protein and other macromolecules, and the purified DNA and RNA is then eluted from the membrane. Many of the manual extraction methods require several centrifugation steps. To reduce hands-on time, operator error, and sample contamination, semi-automated DNA or RNA extraction kits and equipment have been designed and are commercially available.
PCR, sequencing, phylogeny and molecular epidemiology
The mycoplasmas may have evolved through regressive evolution from closely related Gram positive bacteria with low content of guanine plus cytosine (G+C), probably the Clostridia or Erysipelothrix [Bove, 1993; Brown et al., 2007; Razin et al., 1998 ]. The massive gene losses (i.e. genes involved in cell wall and aminoacid biosynthesis) had left mycoplasmas with a coding repertoire of 500 to 2000 genes [Sirand-Pugnet et al., 2007] . The G+C content in DNA of mycoplasmas varies from 23 to 40 mol%, while genome size range is 580-2200 Kbp, much smaller than those of most walled bacteria [Razin et al., 1998 ].
After PCR amplification and sequencing of the conserved 16S rDNA gene sequences from representative members of the Mollicutes, the resulting phylogenetic tree was shown to be monophyletic, arising from a single branch of the Clostridium ramosum branch [International Committee on Systematics of Prokaryotes-Subcommittee on the taxonomy of Mollicutes (ICSP-STM), 2010]. The Mollicutes split into two major branches: the AAP branch, containing the Acholeplasma, Anaeroplasma and Asteroleplasma genera, and the Candidatus Phytoplasma phyla; the other is the SEM branch that includes the Spiroplasma, Entomoplasma, Mesoplasma, Ureaplasma and Mycoplasma genera [Johansson et al., 1998; Maniloff, 1992; Razin et al., 1998 ]. Interestingly, the genus Mycoplasma is polyphyletic, with species clustering within the Spiroplasma, Pneumoniae and Hominis phylogenetic groups [Behbahani et al., 1993; Johansson et al., 1998; Maniloff, 1992] . Nevertheless, additional phylogenetic markers such as the elongation factor EF-Tu (tuf) gene, ribosomal protein genes, the 16S-23S rRNA intergenic sequences, etc, have been already used as complementary comparative data, thus there is no unique phylogenetic tree for Mollicutes [Razin et al., 1998 ].
There are several in-house species-specific end-point or real-time PCR assays developed to detect mycoplasmas in diverse respiratory and urogenital tract infections [Blanchard et al., 1993b; Loens et al., 2003b; Sung et al., 2006; van Kuppeveld et al., 1992; . Of those clinical entities, more than one mycoplasma species are commonly associated as etiologic agents, i.e. urethritis, infertility, pelvic inflammatory disease, etc. [Cassell et al, 1994b; Taylor-Robinson, 1996] . Thus, simultaneous testing of several species-specific or multiplex PCRs to determine all possible pathogenic mycoplasmas associated with a particular clinical entity would be very complicated. Combination of PCR amplification of a given highly conserved target genome sequence with determination of its nucleotide sequences and phylogenetic analysis has been successfully applied for diagnosis and identification of mycoplasmal etiologies in male urethritis cases [Hashimoto et al., 2006; Yoshida et al., 2002] .
Due to their fastidious growth conditions and frequent cross-reactive antigenic profile, identification and typing of human mycoplasmas is a very difficult task. Other approaches termed "Random Amplified Polymorphic DNA" (RAPD) or "Arbitrarily Primed PCR" (AP-PCR), and "Amplified-Fragment Length Polimorphism" (AFLP), are PCR-based typing methods used for intra-and inter-species differentiation of mycoplasma isolates. The RAPD / AP-PCR method involves PCR amplification with a single arbitrary primer at low stringency, while AFLP method selectively amplifies restriction fragments from whole genome. These PCR-based genotyping techniques have allowed faster and reproducible typing of mycoplasmas for epidemiologic studies [Cousin-Allery et al., 2000; Geary & Forsyth, 1996; Grattard et al., 1995; Iverson-Cabral, et al., 2006; Kokotovic et al., 1999; Rawadi, 1998; Schwartz et al., 2009] .
Conclusion
In today's clinical microbiology laboratory, introduction of PCR and other NATs has the potential to increase the speed and accuracy of bacterial detection/identification, especially of those fastidious microorganisms such as mycoplasmas. However, those molecular assays still have serious drawbacks that arise from inadequate acquisition, handling and processing of representative clinical specimens. False negative results ultimately can have a significant impact on patient management.
It is widely accepted that molecular methods are more sensitive and specific than cultureand serology-based diagnostic approaches but, what does a ''positive'' test result mean clinically?. This issue is a matter of controversy for genital mycoplasmas since the duality of their relationship with their host: Is it a commensal or is it a pathogen?. The answer depends of an integral clinical evaluation of patients, where a "signs and symptoms"-focused sampling will improve laboratory diagnosis.
In the clinical setting, when negative results after mycoplasma-specific PCR assays are reported, the type and quality of the specimen, history of antibiotic treatment of the patient, and how representative was the specimen used for the assay, should be taken into account.
Therefore, any set of diagnostic results must be reviewed and critically interpreted before diagnosis and intervention measures are made.
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